NPY and inflammatory bowel disease: Although it has been reported that NPY and VIP levels are increased in human nasal polyps, inflammatory cells of ovalbumin-induced chronic asthma mice, and inflammatory bowel disease (IBD) patients, both peptides are considered immune modulators in airway diseases [82,83,84] and their sophisticated regulation and disease-specific roles should be further investigated in the future.